Logo image of UHS

UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:UHS - US9139031002 - Common Stock

239.43 USD
-4.2 (-1.72%)
Last: 12/1/2025, 8:04:00 PM
239.43 USD
0 (0%)
After Hours: 12/1/2025, 8:04:00 PM
Fundamental Rating

6

Overall UHS gets a fundamental rating of 6 out of 10. We evaluated UHS against 101 industry peers in the Health Care Providers & Services industry. UHS has an excellent profitability rating, but there are some minor concerns on its financial health. UHS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make UHS a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

UHS had positive earnings in the past year.
In the past year UHS had a positive cash flow from operations.
UHS had positive earnings in each of the past 5 years.
In the past 5 years UHS always reported a positive cash flow from operatings.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

With an excellent Return On Assets value of 8.96%, UHS belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
UHS's Return On Equity of 19.18% is amongst the best of the industry. UHS outperforms 88.12% of its industry peers.
UHS has a better Return On Invested Capital (12.33%) than 88.12% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 9.22%.
The 3 year average ROIC (8.28%) for UHS is below the current ROIC(12.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.96%
ROE 19.18%
ROIC 12.33%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of UHS (8.09%) is better than 88.12% of its industry peers.
In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
UHS's Operating Margin of 11.47% is fine compared to the rest of the industry. UHS outperforms 79.21% of its industry peers.
In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
Industry RankSector Rank
OM 11.47%
PM (TTM) 8.09%
GM N/A
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UHS is still creating some value.
Compared to 1 year ago, UHS has less shares outstanding
UHS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for UHS has been reduced compared to a year ago.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 3.28 indicates that UHS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.28, UHS is doing good in the industry, outperforming 69.31% of the companies in the same industry.
The Debt to FCF ratio of UHS is 4.84, which is a neutral value as it means it would take UHS, 4.84 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.84, UHS is doing good in the industry, outperforming 66.34% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
The Debt to Equity ratio of UHS (0.55) is better than 60.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.84
Altman-Z 3.28
ROIC/WACC1.52
WACC8.12%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.03 indicates that UHS should not have too much problems paying its short term obligations.
The Current ratio of UHS (1.03) is worse than 70.30% of its industry peers.
A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
With a Quick ratio value of 0.96, UHS is not doing good in the industry: 68.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.96
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.07% over the past year.
Measured over the past years, UHS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.74% on average per year.
UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
Measured over the past years, UHS shows a small growth in Revenue. The Revenue has been growing by 6.82% on average per year.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%

3.2 Future

Based on estimates for the next years, UHS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.53% on average per year.
Based on estimates for the next years, UHS will show a small growth in Revenue. The Revenue will grow by 4.90% on average per year.
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.51 indicates a reasonable valuation of UHS.
Compared to the rest of the industry, the Price/Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 89.11% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.11. UHS is valued rather cheaply when compared to this.
UHS is valuated reasonably with a Price/Forward Earnings ratio of 10.27.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 89.11% of the companies listed in the same industry.
UHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.51
Fwd PE 10.27
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaply inside the industry as 82.18% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than the industry average as 74.26% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.45
EV/EBITDA 7.66
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UHS has a very decent profitability rating, which may justify a higher PE ratio.
UHS's earnings are expected to grow with 15.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)1.07
EPS Next 2Y18.34%
EPS Next 3Y15.88%

5

5. Dividend

5.1 Amount

UHS has a yearly dividend return of 0.33%, which is pretty low.
UHS's Dividend Yield is a higher than the industry average which is at 2.47.
Compared to an average S&P500 Dividend Yield of 2.32, UHS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.33%

5.2 History

On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

3.78% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (12/1/2025, 8:04:00 PM)

After market: 239.43 0 (0%)

239.43

-4.2 (-1.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27 2025-10-27/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners98.12%
Inst Owner Change-2.3%
Ins Owners5.45%
Ins Owner Change16.62%
Market Cap14.96B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts70.77
Price Target249.24 (4.1%)
Short Float %3.44%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 0.33%
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-Date12-01 2025-12-01 (0.2)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)7.55%
PT rev (3m)12.15%
EPS NQ rev (1m)3.52%
EPS NQ rev (3m)4.2%
EPS NY rev (1m)2.74%
EPS NY rev (3m)3.25%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 11.51
Fwd PE 10.27
P/S 0.88
P/FCF 15.45
P/OCF 7.68
P/B 2.09
P/tB 4.7
EV/EBITDA 7.66
EPS(TTM)20.8
EY8.69%
EPS(NY)23.3
Fwd EY9.73%
FCF(TTM)15.5
FCFY6.47%
OCF(TTM)31.18
OCFY13.02%
SpS271.97
BVpS114.75
TBVpS50.9
PEG (NY)0.4
PEG (5Y)1.07
Graham Number231.74
Profitability
Industry RankSector Rank
ROA 8.96%
ROE 19.18%
ROCE 16%
ROIC 12.33%
ROICexc 12.44%
ROICexgc 18.59%
OM 11.47%
PM (TTM) 8.09%
GM N/A
FCFM 5.7%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4.84
Debt/EBITDA 1.55
Cap/Depr 162.72%
Cap/Sales 5.77%
Interest Coverage 15.36
Cash Conversion 76.35%
Profit Quality 70.41%
Current Ratio 1.03
Quick Ratio 0.96
Altman-Z 3.28
F-Score8
WACC8.12%
ROIC/WACC1.52
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year55.52%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%

UNIVERSAL HEALTH SERVICES-B / UHS FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


What is the valuation status for UHS stock?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for UHS stock?

The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 11.51 and the Price/Book (PB) ratio is 2.09.


Can you provide the financial health for UHS stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.